How genes and environment interact to raise risk of congenital heart defects

October 19, 2017, Nationwide Children's Hospital
heart
Human heart. Credit: copyright American Heart Association

Infants of mothers with diabetes have a three- to five-fold increased risk of congenital heart defects. Such developmental defects are likely caused by a combination of genetic and environmental factors. However, the molecular mechanisms by which maternal diabetes disrupts normal heart development in genetically susceptible individuals remain unclear.

In a new study, researchers led by Vidu Garg, MD, director of the Center for Cardiovascular Research in The Research Institute at Nationwide Children's and the Nationwide Foundation Endowed Chair in Cardiovascular Research, describe a gene-environment interaction resulting in congenital heart defects in both mouse and fly model systems.

"We had previously shown an interaction between two genes, Endothelial Nitric Oxide Synthase and Notch1, would result in more severe types of congenital heart defects in animal models," says Dr. Garg, who is also professor of pediatrics and molecular genetics at The Ohio State University.

"Diabetes is known to be associated with decreased levels in blood vessels. We hypothesized that maternal diabetes, in combination with a mutation in Notch1, would result in a higher risk of ."

In the new study, a collaboration with Zhe Han, PhD, at Children's National in Washington, D. C., the researchers show that maternal hyperglycemia reduces the chromatin accessibility of the Endothelial Nitric Oxide Synthase gene, resulting in decreased production. This loss of nitric oxide is associated with an increase in expression of Jarid2, a known repressor of the Notch1 gene. This directly inhibited Notch1 expression to levels below a critical threshold necessary for normal heart development.

This study lends support to a gene-environment interaction model where maternal hyperglycemia raises the risk of congenital heart defects by reducing Notch1 expression. The results reveal the epigenetic machinery by which maternal hyperglycemia disrupts the Nitric Oxide and Notch1 signaling pathways, leading to congenital heart defects.

"Only a subset of infants that are exposed to hyperglycemia develop a congenital heart , which supports the idea that there are genetically susceptible individuals," says Dr. Garg, who is also a pediatric cardiologist in The Heart Center at Nationwide Children's Hospital. "That raises the question: Can we identify those genetically susceptible infants and their mothers?"

Another question Dr. Garg is pursuing concerns the relationship between changes in maternal glucose level and changes in gene expression level.

"Is this a true dose-response curve? Do subtle elevations in blood glucose level during early pregnancy, when the heart is developing, increase the risk of a ?" asks Dr. Garg. "If so, can we identify expectant mothers who may be at risk for having a child with congenital heart defects even with modest elevations in blood glucose, as they may need closer monitoring of blood glucose levels during early pregnancy?"

The answers to these questions will have to come further down the road, says Dr. Garg. It may be some time before this knowledge can be used clinically, but this initial study provides important evidence that the risk of maternal diabetes-associated congenital defects can be influenced by genetic susceptibilities.

Explore further: New mouse model helps explain gene discovery in congenital heart disease

More information: Madhumita Basu et al, Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease, JCI Insight (2017). DOI: 10.1172/jci.insight.95085

Related Stories

New mouse model helps explain gene discovery in congenital heart disease

June 26, 2012
Scientists now have clues to how a gene mutation discovered in families affected with congenital heart disease leads to underdevelopment of the walls that separate the heart into four chambers. A Nationwide Children's Hospital ...

Researchers identify genetic mutation linked to congenital heart disease

July 29, 2013
A mutation in a gene crucial to normal heart development could play a role in some types of congenital heart disease—the most common birth defect in the U.S. The finding, from a team in The Research Institute at Nationwide ...

Kids with heart defects face learning challenges, inadequate school support

February 22, 2017
Children with all types of congenital heart defects face learning challenges in elementary school, but many may not be receiving adequate education assistance, according to a new study in Circulation: Cardiovascular Quality ...

Some newborns don't get heart defect, hearing loss tests

August 25, 2017
(HealthDay)—Some newborns in the United States still aren't getting screened for hearing loss or congenital heart disease, a new report shows.

Tracking blood sugar in pregnancy might lower heart defect risk for baby

November 14, 2016
(HealthDay)—Increases in a woman's blood sugar levels during early pregnancy may affect her baby's risk of congenital heart defects, a new study suggests.

Preeclampsia associated with increased risk of heart defects in infants

October 20, 2015
An analysis of more than 1.9 million mother and infant pairs finds that preeclampsia was significantly associated with noncritical heart defects in offspring, and preeclampsia with onset before 34 weeks was associated with ...

Recommended for you

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...

Heart failure patients shouldn't stop meds even if condition improves: study

November 13, 2018
(HealthDay)—There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds.

Bypass beats stents for diabetics with heart trouble: study

November 13, 2018
(HealthDay)—People with both diabetes and multiple clogged heart arteries live longer if they undergo bypass surgery rather than have their blood vessels reopened with stents, according to follow-up results from a landmark ...

Kawasaki disease: One disease, multiple triggers

November 12, 2018
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography, and international collaborators have evidence that Kawasaki Disease (KD) does not have a single cause. By studying ...

New treatment significantly reduces cardiovascular events when combined with statins

November 12, 2018
Statins are the most commonly used treatment for cardiovascular disease. Despite reducing certain risk factors, if triglyceride levels remain high with use of statins, there is still a significant risk for heart attack, stroke ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.